pharmaceuticals

Higher, faster, further: Shop Apotheke is growing rapidly thanks to e-prescriptions. But growth comes at a price in the form of high marketing costs. CEO Olaf Heinrich explains the strategy to Börsen-Zeitung.

Stefan Oelrich, Member of Bayer's Board of Management and Head of the Pharmaceuticals Division, is confident about the development pipeline. As one important patent expires, he points to a range of new products that will generate big sales.

Long-suffering Bayer shareholders are being asked to stump up 8 billion euros in a cash call. What looks like a bold move might just be courage born out of desperation.